0001140361-17-027822.txt : 20170713 0001140361-17-027822.hdr.sgml : 20170713 20170713173915 ACCESSION NUMBER: 0001140361-17-027822 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170712 FILED AS OF DATE: 20170713 DATE AS OF CHANGE: 20170713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioRestorative Therapies, Inc. CENTRAL INDEX KEY: 0001505497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 911835664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 760-8100 MAIL ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Stem Cell Assurance, Inc. DATE OF NAME CHANGE: 20101110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clyde Mandy D. CENTRAL INDEX KEY: 0001527239 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37603 FILM NUMBER: 17964204 MAIL ADDRESS: STREET 1: STEM CELL ASSURANCE, INC. STREET 2: 555 HERITAGE DRIVE CITY: JUPITER STATE: FL ZIP: 33458 FORMER NAME: FORMER CONFORMED NAME: Clark Mandy D. DATE OF NAME CHANGE: 20110802 4 1 doc1.xml FORM 4 X0306 4 2017-07-12 0 0001505497 BioRestorative Therapies, Inc. BRTX 0001527239 Clyde Mandy D. 40 MARCUS DRIVE MELVILLE NY 11747 0 1 0 0 VP of Operations Stock Option 4.7 2010-12-15 2020-12-14 Common Stock 4000 4000 D Stock Option 4.7 2021-04-20 Common Stock 300 300 D Stock Option 4.7 2022-02-09 Common Stock 1500 1500 D Stock Option 4.7 2022-12-07 Common Stock 2500 2500 D Stock Option 4.7 2023-10-04 Common Stock 4000 4000 D Stock Option 4.7 2024-02-18 Common Stock 6250 6250 D Stock Option 4.7 2024-10-23 Common Stock 10000 10000 D Stock Option 4.7 2025-09-04 Common Stock 25500 25500 D Stock Option 3.73 2026-06-10 Common Stock 40000 40000 D Stock Option 2.8 2017-07-12 4 A 0 30000 0 A 2027-07-12 Common Stock 30000 30000 D The option is exercisable to the extent of 100 shares on each of April 21, 2011, April 21, 2012 and April 21, 2013. The option is exercisable to the extent of 750 shares on each of February 10, 2012 and February 10, 2013. The option is exercisable to the extent of 1,250 shares on each of December 7, 2012 and December 7, 2013. The option is exercisable to the extent of 2,000 shares on each of October 4, 2013 and October 4, 2014. The option is exercisable to the extent of 2,084 shares on February 18, 2014, and 2,083 shares on each of February 18, 2015 and February 18, 2016. The option is exercisable to the extent of 3,334 shares on October 23, 2015 and 3,333 shares on each of October 23, 2016 and October 23, 2017. The option is exercisable to the extent of 8,500 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. The option is exercisable to the extent of 13,334 shares on June 10, 2017 and 13,333 shares on each of June 10, 2018 and June 10, 2019. The option is exercisable to the extent of 10,000 shares on each of July 12, 2018, July 12, 2019 and July 12, 2020. /s/ Mandy D. Clyde 2017-07-13